Search
Ecomustine
go.drugbank.com/drugs/DB20177ExperimentalEcomustine is a small molecule drug. The usage of the INN stem '-mustine' in the name indicates that Ecomustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative.
Itrocainide
go.drugbank.com/drugs/DB20210ExperimentalItrocainide is a small molecule drug. The usage of the INN stem '-cain-' in the name indicates that Itrocainide is a class I antiarrhythmic, procainamide and lidocaine derivative.
Alestramustine
go.drugbank.com/drugs/DB20270ExperimentalAlestramustine is a small molecule drug. The usage of the INN stem '-mustine' in the name indicates that Alestramustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative.
Ambamustine
go.drugbank.com/drugs/DB20805ExperimentalAmbamustine is a small molecule drug. The usage of the INN stem '-mustine' in the name indicates that Ambamustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative.
AZD-7687
go.drugbank.com/drugs/DB14949InvestigationalAZD-7687 is under investigation in clinical trial NCT01119352 (AZD7687 Multiple Ascending Dose Study).
Nattokinase
go.drugbank.com/drugs/DB15329InvestigationalNattokinase is under investigation in clinical trial NCT00749801 (Efficacy and Safety of Geneferm Nattokinase).
Vidofludimus
go.drugbank.com/drugs/DB15446InvestigationalVidofludimus is under investigation in clinical trial NCT03722576 (Vidofludimus Calcium for Primary Sclerosing Cholangitis).
Dapiglutide
go.drugbank.com/drugs/DB19182InvestigationalDapiglutide is under investigation in clinical trial NCT05788601 (Dapiglutide for the Treatment of Obesity).
Synonyms: -ASPARTYL-N6-(N-(17-CARBOXY-1-OXOHEPTADECYL)-L-.GAMMA.-GLUTAMYL)-L, Human glucagon like peptide-2 (glp-2) analogue; n6.16-(n-(17-carboxyheptadecanoyl)-l-.gamma.Anti-SARS-CoV-2 REGN-COV2
go.drugbank.com/drugs/DB15691InvestigationalThis drug is a combination of the antibodies REGN10933 and REGN10987, derived from humanized VelocImmune® mice in addition to blood samples from patients who have recovered from COVID-19. … [L14303] Two upcoming publications in the journal, _Science_, will provide additional information about preclinical research with the Anti-SARS-COV-2 REGN-COV2 antibody cocktail.